Published in Expert Rev Mol Med on August 31, 2006
An Assessment of Cognitive Function in Irritable Bowel Syndrome | NCT01304355
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci (2012) 4.95
Kynurenine pathway metabolites in humans: disease and healthy States. Int J Tryptophan Res (2009) 2.01
Brain-gut-microbe communication in health and disease. Front Physiol (2011) 1.59
Maternal dietary tryptophan deficiency alters cardiorespiratory control in rat pups. J Appl Physiol (1985) (2010) 1.51
The role of microbiome in central nervous system disorders. Brain Behav Immun (2013) 1.34
The microbiome: stress, health and disease. Mamm Genome (2013) 1.24
Of mice, rats and men: Revisiting the quinolinic acid hypothesis of Huntington's disease. Prog Neurobiol (2009) 1.18
Effects of Kynurenine Pathway Metabolites on Intracellular NAD Synthesis and Cell Death in Human Primary Astrocytes and Neurons. Int J Tryptophan Res (2009) 1.07
Irritable bowel syndrome: a microbiome-gut-brain axis disorder? World J Gastroenterol (2014) 1.06
Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort. BMC Gastroenterol (2009) 1.00
LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-gamma-independent manner by a JNK signaling pathway in primary murine microglia. Brain Behav Immun (2009) 0.95
Expression of tryptophan 2,3-dioxygenase and production of kynurenine pathway metabolites in triple transgenic mice and human Alzheimer's disease brain. PLoS One (2013) 0.93
Tryptophan, Neurodegeneration and HIV-Associated Neurocognitive Disorder. Int J Tryptophan Res (2010) 0.90
The importance of NAD in multiple sclerosis. Curr Pharm Des (2009) 0.89
Immune privilege as an intrinsic CNS property: astrocytes protect the CNS against T-cell-mediated neuroinflammation. Mediators Inflamm (2013) 0.86
A Distinct Profile of Tryptophan Metabolism along the Kynurenine Pathway Downstream of Toll-Like Receptor Activation in Irritable Bowel Syndrome. Front Pharmacol (2012) 0.85
Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules. J Biomed Biotechnol (2010) 0.83
Vasoconstrictor and vasodilator responses to tryptamine of rat-isolated perfused mesentery: comparison with tyramine and β-phenylethylamine. Br J Pharmacol (2012) 0.83
Species and cell types difference in tryptophan metabolism. Int J Tryptophan Res (2013) 0.82
From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways. Mol Psychiatry (2016) 0.82
The kynurenine pathway in stem cell biology. Int J Tryptophan Res (2013) 0.81
The biochemical pathways of central nervous system neural degeneration in niacin deficiency. Neural Regen Res (2014) 0.81
Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome. Psychopharmacology (Berl) (2014) 0.80
L-Tryptophan Production by Auxotrophic and Analogue Resistant Mutants of Aureobacterium flavescens. Int J Tryptophan Res (2011) 0.79
Applications of different weighting schemes to improve pathway-based analysis. Comp Funct Genomics (2011) 0.77
Tryptophan Biochemistry: Structural, Nutritional, Metabolic, and Medical Aspects in Humans. J Amino Acids (2016) 0.77
A Brief Historic Overview of Clinical Disorders Associated with Tryptophan: The Relevance to Chronic Fatigue Syndrome (CFS) and Fibromyalgia (FM). Int J Tryptophan Res (2012) 0.77
Raman spectroscopy detects melanoma and the tissue surrounding melanoma using tissue-engineered melanoma models. Appl Spectrosc Rev (2016) 0.77
Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1). J Biol Chem (2016) 0.77
Cutting back on the essentials: Can manipulating intake of specific amino acids modulate health and lifespan? Ageing Res Rev (2016) 0.76
Tryptophan research in panic disorder. Int J Tryptophan Res (2008) 0.75
Plasma kynurenic acid concentration in patients undergoing cardiac surgery: effect of anaesthesia. Arch Immunol Ther Exp (Warsz) (2014) 0.75
Linkage analysis of obesity phenotypes in pre- and post-menopausal women from a United States mid-western population. BMC Med Genet (2010) 0.75
Microbiome-Gut-Brain Axis: A Pathway for Improving Brainstem Serotonin Homeostasis and Successful Autoresuscitation in SIDS-A Novel Hypothesis. Front Pediatr (2017) 0.75
Tryptophan oxidative metabolism catalyzed by geobacillus stearothermophilus: a thermophile isolated from kuwait soil contaminated with petroleum hydrocarbons. Int J Tryptophan Res (2011) 0.75
Cane molasses as a source of precursors in the bioproduction of tryptophan by Bacillus subtilis. Iran J Microbiol (2013) 0.75
High-Fat Diet and Voluntary Chronic Aerobic Exercise Recover Altered Levels of Aging-Related Tryptophan Metabolites along the Kynurenine Pathway. Exp Neurobiol (2017) 0.75
Cross Talk: The Microbiota and Neurodevelopmental Disorders. Front Neurosci (2017) 0.75
5-HT modulation of pain perception in humans. Psychopharmacology (Berl) (2017) 0.75
Close association between intestinal microbiota and irritable bowel syndrome. Eur J Clin Microbiol Infect Dis (2017) 0.75
The HPA axis in major depression: classical theories and new developments. Trends Neurosci (2008) 3.47
Interaction of the glucocorticoid receptor with the chromatin landscape. Mol Cell (2008) 3.42
Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol Cell (2011) 2.97
Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol (2009) 2.46
Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology (2008) 2.37
Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol (2006) 1.89
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2005) 1.88
Uncritical positive regard? Issues in the efficacy and safety of psychotherapy. J Psychopharmacol (2008) 1.80
Role of GABA in anxiety and depression. Depress Anxiety (2007) 1.79
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin. Proc Natl Acad Sci U S A (2012) 1.79
Oxytocin attenuates stress-induced c-fos mRNA expression in specific forebrain regions associated with modulation of hypothalamo-pituitary-adrenal activity. J Neurosci (2004) 1.75
Lung remodeling in pulmonary tuberculosis. J Infect Dis (2005) 1.71
The size, burden and cost of disorders of the brain in the UK. J Psychopharmacol (2013) 1.62
Acute tryptophan depletion. Part II: clinical effects and implications. Aust N Z J Psychiatry (2005) 1.62
GABA system dysfunction in autism and related disorders: from synapse to symptoms. Neurosci Biobehav Rev (2012) 1.61
Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis. Curr Opin Pulm Med (2005) 1.60
Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Infect Dis (2008) 1.59
Anatomic and functional topography of the dorsal raphe nucleus. Ann N Y Acad Sci (2004) 1.58
Cortisol pulsatility and its role in stress regulation and health. Front Neuroendocrinol (2004) 1.55
Functional topography of serotonergic systems supports the Deakin/Graeff hypothesis of anxiety and affective disorders. J Psychopharmacol (2013) 1.54
A tale of two Es. J Psychopharmacol (2006) 1.53
Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann N Y Acad Sci (2008) 1.48
Substitution therapy for alcoholism: time for a reappraisal? J Psychopharmacol (2011) 1.47
MDMA, politics and medical research: have we thrown the baby out with the bathwater? J Psychopharmacol (2007) 1.42
Kisspeptin signalling in the hypothalamic arcuate nucleus regulates GnRH pulse generator frequency in the rat. PLoS One (2009) 1.42
Dopamine and social anxiety disorder. Rev Bras Psiquiatr (2006) 1.38
Prescribing antidepressants post Cipriani et al. J Psychopharmacol (2009) 1.37
Inflammation, sanitation, and consternation: loss of contact with coevolved, tolerogenic microorganisms and the pathophysiology and treatment of major depression. Arch Gen Psychiatry (2010) 1.37
Human taste thresholds are modulated by serotonin and noradrenaline. J Neurosci (2006) 1.36
Psychotropic drugs, cardiac arrhythmia, and sudden death. J Clin Psychopharmacol (2003) 1.36
Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol (2014) 1.36
Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis. Proc Biol Sci (2010) 1.35
Functional topography of midbrain and pontine serotonergic systems: implications for synaptic regulation of serotonergic circuits. Psychopharmacology (Berl) (2010) 1.32
The origin of glucocorticoid hormone oscillations. PLoS Biol (2012) 1.30
Neural responses to territorial challenge and nonsocial stress in male song sparrows: segregation, integration, and modulation by a vasopressin V1 antagonist. Horm Behav (2004) 1.29
Neuropeptide binding reflects convergent and divergent evolution in species-typical group sizes. Horm Behav (2006) 1.29
Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain. J Comp Neurol (2009) 1.24
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2014) 1.22
Amphetamine, past and present--a pharmacological and clinical perspective. J Psychopharmacol (2013) 1.22
Neuro-evolutionary patterning of sociality. Proc Biol Sci (2005) 1.21
Regulation of inflammation by interleukin-4: a review of "alternatives". J Leukoc Biol (2012) 1.20
Antidepressant-induced jitteriness/anxiety syndrome: systematic review. Br J Psychiatry (2009) 1.20
Corticotropin-releasing factor in the dorsal raphe nucleus increases medial prefrontal cortical serotonin via type 2 receptors and median raphe nucleus activity. Eur J Neurosci (2008) 1.19
Measuring endogenous 5-HT release by emission tomography: promises and pitfalls. J Cereb Blood Flow Metab (2010) 1.16
The inhibitory effects of neurokinin B on GnRH pulse generator frequency in the female rat. Endocrinology (2011) 1.16
Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology (2010) 1.16
Increased expression of mRNA encoding interleukin (IL)-4 and its splice variant IL-4delta2 in cells from contacts of Mycobacterium tuberculosis, in the absence of in vitro stimulation. Immunology (2004) 1.15
ACTH-dependent ultradian rhythm of corticosterone secretion. Endocrinology (2011) 1.15
The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study. Synapse (2007) 1.15
Striatal dopamine D₂/D₃ receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage (2012) 1.13
Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry Res (2003) 1.13
Consequences of post-weaning social isolation on anxiety behavior and related neural circuits in rodents. Front Behav Neurosci (2009) 1.13
Stress-related serotonergic systems: implications for symptomatology of anxiety and affective disorders. Cell Mol Neurobiol (2012) 1.11
Functional connectivity analysis of the neural circuits of opiate craving: "more" rather than "different"? Neuroimage (2003) 1.10
In vivo and in vitro studies of a novel cytokine, interleukin 4delta2, in pulmonary tuberculosis. Am J Respir Crit Care Med (2005) 1.10
Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males. J Neurosci (2010) 1.10
5-HT radioligands for human brain imaging with PET and SPECT. Med Res Rev (2011) 1.10
Effects of acute tyrosine/phenylalanine depletion on the selective processing of smoking-related cues and the relative value of cigarettes in smokers. Psychopharmacology (Berl) (2007) 1.10
Cape Town consensus on posttraumatic stress disorder. CNS Spectr (2009) 1.09
Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. J Neurosci (2006) 1.09
Behavioral and cardiovascular effects of 7.5% CO2 in human volunteers. Depress Anxiety (2005) 1.09
Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety. J Clin Psychiatry (2004) 1.08
Chemoarchitectonic subdivisions of the songbird septum and a comparative overview of septum chemical anatomy in jawed vertebrates. J Comp Neurol (2004) 1.08
Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors. Biol Psychiatry (2006) 1.08
Which antidepressants have demonstrated superior efficacy? A review of the evidence. Int Clin Psychopharmacol (2007) 1.07
Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci (2013) 1.07
Hypothalamic-pituitary-adrenal axis activation in obstructive sleep apnea: the effect of continuous positive airway pressure therapy. J Clin Endocrinol Metab (2009) 1.07
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder. Curr Opin Pharmacol (2005) 1.07
Circadian and ultradian rhythms of free glucocorticoid hormone are highly synchronized between the blood, the subcutaneous tissue, and the brain. Endocrinology (2012) 1.07
The hygiene hypothesis and psychiatric disorders. Trends Immunol (2008) 1.07
Differential effects of exposure to low-light or high-light open-field on anxiety-related behaviors: relationship to c-Fos expression in serotonergic and non-serotonergic neurons in the dorsal raphe nucleus. Brain Res Bull (2007) 1.06
A functional subset of serotonergic neurons in the rat ventrolateral periaqueductal gray implicated in the inhibition of sympathoexcitation and panic. Ann N Y Acad Sci (2004) 1.06
Induction of c-Fos in 'panic/defence'-related brain circuits following brief hypercarbic gas exposure. J Psychopharmacol (2010) 1.06
WCA recommendations for the long-term treatment of generalized anxiety disorder. CNS Spectr (2003) 1.06
GPR54-dependent stimulation of luteinizing hormone secretion by neurokinin B in prepubertal rats. PLoS One (2012) 1.05
16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. J Infect Dis (2004) 1.05
Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci (2012) 1.05
Harms associated with psychoactive substances: findings of the UK National Drug Survey. J Psychopharmacol (2009) 1.05
Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study. Br J Psychiatry (2008) 1.04
Molecular dynamics of ultradian glucocorticoid receptor action. Mol Cell Endocrinol (2011) 1.03
Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats. J Psychopharmacol (2005) 1.03
Putative isotocin distributions in sonic fish: relation to vasotocin and vocal-acoustic circuitry. J Comp Neurol (2003) 1.03
Gamma hydroxy butyrate abuse and dependency. J Psychopharmacol (2005) 1.03
Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis. Schizophr Bull (2012) 1.03
Urocortin 2 increases c-Fos expression in topographically organized subpopulations of serotonergic neurons in the rat dorsal raphe nucleus. Brain Res (2005) 1.02
The importance of models of infection in the study of disease resistance. Trends Microbiol (2002) 1.02
Neural pathways underlying lactate-induced panic. Neuropsychopharmacology (2007) 1.02
Evidence supporting a role for corticotropin-releasing factor type 2 (CRF2) receptors in the regulation of subpopulations of serotonergic neurons. Brain Res (2006) 1.02
Is there cognitive impairment in clinically 'healthy' abstinent alcohol dependence? Alcohol Alcohol (2005) 1.01
Stress responsiveness varies over the ultradian glucocorticoid cycle in a brain-region-specific manner. Endocrinology (2010) 1.01
Neural responses to aggressive challenge correlate with behavior in nonbreeding sparrows. Neuroreport (2005) 1.01
Myobacterium tuberculosis induces selective up-regulation of TLRs in the mononuclear leukocytes of patients with active pulmonary tuberculosis. J Immunol (2006) 1.01
A neurodevelopmental model for anorexia nervosa. Physiol Behav (2003) 1.00
Anhedonia revisited: is there a role for dopamine-targeting drugs for depression? J Psychopharmacol (2013) 1.00
Mycobacterium vaccae induces a population of pulmonary CD11c+ cells with regulatory potential in allergic mice. Eur J Immunol (2004) 1.00